- Home
- MRNA vs PRI Comparison
MRNA vs PRI Comparison
Compare MRNA & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PRI
- Stock Information
- Founded
- MRNA 2010
- PRI 1927
- Country
- MRNA United States
- PRI United States
- Employees
- MRNA N/A
- PRI N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PRI Life Insurance
- Sector
- MRNA Health Care
- PRI Finance
- Exchange
- MRNA Nasdaq
- PRI Nasdaq
- Market Cap
- MRNA 9.8B
- PRI 8.6B
- IPO Year
- MRNA 2018
- PRI N/A
- Fundamental
- Price
- MRNA $25.18
- PRI $261.09
- Analyst Decision
- MRNA Hold
- PRI Buy
- Analyst Count
- MRNA 15
- PRI 7
- Target Price
- MRNA $37.15
- PRI $316.00
- AVG Volume (30 Days)
- MRNA 10.8M
- PRI 145.0K
- Earning Date
- MRNA 11-06-2025
- PRI 11-05-2025
- Dividend Yield
- MRNA N/A
- PRI 1.60%
- EPS Growth
- MRNA N/A
- PRI 61.36
- EPS
- MRNA N/A
- PRI 20.26
- Revenue
- MRNA $3,078,000,000.00
- PRI $3,220,913,000.00
- Revenue This Year
- MRNA N/A
- PRI $4.38
- Revenue Next Year
- MRNA $11.12
- PRI $5.41
- P/E Ratio
- MRNA N/A
- PRI $12.27
- Revenue Growth
- MRNA N/A
- PRI 7.56
- 52 Week Low
- MRNA $23.15
- PRI $230.98
- 52 Week High
- MRNA $56.70
- PRI $307.91
- Technical
- Relative Strength Index (RSI)
- MRNA 44.51
- PRI 40.04
- Support Level
- MRNA $24.25
- PRI $257.06
- Resistance Level
- MRNA $29.20
- PRI $266.12
- Average True Range (ATR)
- MRNA 1.50
- PRI 5.84
- MACD
- MRNA -0.13
- PRI -0.51
- Stochastic Oscillator
- MRNA 16.97
- PRI 27.39
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PRI Primerica Inc.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.